Conversely, high RALB expression was associated with better outcomes across BC (p = 8.5 × 10−5, Supplementary Figure S1A) and was not prognostic of survival within the individual subtypes tested (Figure 1A lower panels. The gene discussed is RALB; the disease is breast cancer.